As Americans continue to embrace pot—as medicine and for recreational use—opponents are turning to a set of academic researchers to claim that policymakers should avoid relaxing restrictions around marijuana. It's too dangerous, risky, and untested, they say. Just as drug company-funded research has become incredibly controversial in recent years, forcing major medical schools and journals to institute strict disclosure requirements, could there be a conflict of interest issue in the pot debate? (See also: The real reason pot is still illegal)
That the black market in Colorado bustles in the emerging days of legalisation is not unexpected. By some reckonings, it will continue as long as residents of other states look to Colorado as the nation’s cannabis cookie jar. And as long as its legal retail competition keeps prices high and is taxed at rates surpassing 30%. “I don’t know who is buying for recreational use at dispensaries unless it’s white, middle-class people and out-of-towners,” said a longtime community activist. “Everyone I know still has the guy on the street that they hook up with.”
The federal law that makes possession of marijuana a crime has its origins in legislation that was passed in an atmosphere of hysteria during the 1930s and that was firmly rooted in prejudices against Mexican immigrants and African-Americans, who were associated with marijuana use at the time. This racially freighted history lives on in current federal policy, which is so driven by myth and propaganda that it is almost impervious to reason.
No sooner had the Times published its opening editorials advocating legalization of marijuana than the White House fired back with an unconvincing response on its website. It argued that marijuana should remain illegal because of public health problems “associated” (always a slippery word) with increased marijuana use. Careful readers will immediately see the White House statement for what it is: A pro forma response to a perceived public relations crisis, not a full-fledged review of all the scientific evidence.
America’s four-decade war on drugs is responsible for many casualties, but the criminalization of marijuana has been perhaps the most destructive part of that war. The toll can be measured in dollars — billions of which are thrown away each year in the aggressive enforcement of pointless laws. It can be measured in years — whether wasted behind bars or stolen from a child who grows up fatherless. And it can be measured in lives — those damaged if not destroyed by the shockingly harsh consequences that can follow even the most minor offenses.
It took 13 years for the United States to come to its senses and end Prohibition, 13 years in which people kept drinking, otherwise law-abiding citizens became criminals and crime syndicates arose and flourished. It has been more than 40 years since Congress passed the current ban on marijuana, inflicting great harm on society just to prohibit a substance far less dangerous than alcohol. The federal government should repeal the ban on marijuana. (See also: Why the New York Times editorial series calling for marijuana legalization is such a big deal and Evolving on Marijuana)
Many longtime supporters of drug courts have become dismayed by the extent to which the courts now reach into the lives of people whose only infraction was to light up a joint. More Americans are arrested for pot possession than any other drug offense, with more than 650,000 such arrests in 2012. Some pot users who might have simply faced a fine in the regular court system are instead getting moved into the drug-court system for months on end. They are often required to pay for expensive treatment programs and risk jail time if they break program rules along the way. (See also: Moving Away from Drug Courts)
Martin Jelsma, politólogo especializado en políticas internacionales de droga, ha asesorado al gobierno de Uruguay y augura ahora un efecto dominó que ni las restrictivas convenciones internacionales ni los Estados Unidos no podrán parar. "A nivel internacional, después de décadas con políticas alternativas, por primera vez un país y dos estados de Estados Unidos empiezan con la regulación de toda la cadena del cannabis. Nunca había pasado antes, ni siquiera en los Países Bajos, con los coffee shops, donde la producción sigue prohibida. Son los primeros escenarios con una legalización controlada y estoy convencido que es el inicio de cambios que otros países van a seguir."
Oregon voters will decide whether to legalize marijuana for recreational use after state elections officials said the measure qualified for the November 2014 ballot. The measure would allow adults 21 and older to buy and possess marijuana and would give the Oregon Liquor Control Commission the job of regulating and taxing the drug. Voters rejected a legalization measure two years ago, but little money was spent promoting it. By contrast, New Approach Oregon, the group behind the initiative, has received contributions from some of the same donors who backed successful marijuana initiatives in Washington and Colorado.
The United States federal government is considering easing its position on marijuana, reclassifying it as a less dangerous drug in what marijuana advocates say reflects the changing attitudes nationwide. But drug specialists fear the watershed moment for marijuana research could be a slippery slope for addicts. The Food and Drug Administration (FDA) is reviewing marijuana’s classification to consider changing it from a Schedule I drug. (See also: FDA to evaluate marijuana for potential reclassification as less dangerous drug)
The dynamics of reform in the Americas continues. This time, the momentum comes from the Caribbean region. Jamaica and other Caribbean Community (CARICOM) member states are now moving to change their marijuana laws. Among the proposed changes discussed in Jamaica were the decriminalisation of possession of small amounts of ganja for recreational and religious use and cultivating it for medicinal purposes.
On July 8th Washington became the second state after Colorado to offer recreational pot-smokers a chance to buy weed legally at a local store. Marijuana is still illegal in most of America. But there are substantial activities towards more liberal policies. In 23 states the medicinal use of marijuana is allowed and more states are considering legalisation. Oregon and Alaska will vote on legalisation in November; Floridians will decide on permitting medical use. President Barack Obama has chosen to take a hand’s-off approach to the issue of legalisation in Washington and Colorado. Yet if a drug hawk were to succeed President Obama in 2016, a clampdown on pot could well be revived.
The Drug Enforcement Administration (DEA) has found itself under attack in Congress as it holds its ground against marijuana legalization while the resolve of longtime political allies — and the White House and Justice Department to which it reports — rapidly fades. How much the agency's stock has fallen was readily apparent in the House debate, when Rep. Jared Polis (D-Colo.) denounced the agency's longtime chief.
La reforma al control de drogas que se está emprendiendo en las Américas, y que presiona los límites del marco jurídico mundial establecido en tres convenciones de la ONU, se ha convertido en un tema delicado. La despenalización de la tenencia para consumo personal en varios países de América Latina y el establecimiento de una sala supervisada para inyección en Vancouver, Canadá, han provocado disputas legales prolongadas con la Junta Internacional de Fiscalización de Estupefacientes (JIFE), el órgano cuasi-judicial para la aplicación de los convenios.
Washington state issued its first retail marijuana licenses Monday, a day ahead of the start of legal sales. And 21 hours before the only store licensed to sell in Seattle was set to open, a line already was forming. The start of legal pot sales in Washington on Tuesday marks a major step that's been 20 months in the making. Washington and Colorado stunned much of the world by voting in November 2012 to legalize marijuana for adults over 21. (See also: State’s retail pot gets rolling Tuesday and Few pot stores ready for business on opening day)
When the poster child for marijuana legalization is released from a U.S. prison later this week, he'll be re-entering a world where many of his ideas have taken root and in some places have sprouted right up. Marc Emery, Canada’s self-styled “Prince of Pot,” concludes a five-year sentence and will emerge into a lucrative marijuana landscape, where two U.S. states are now issuing recreational pot licences, medical growers are reaping profits and investors aren’t hedging on potential opportunities.
When recreational marijuana stores first opened their doors in the US state of Colorado on January 1, opponents predicted dire consequences: an influx of drug traffickers, a spike in fatal car accidents, and more crime. For their part, supporters claimed that legal weed could raise millions of dollars in tax revenue. Six months later, what have the results been? (See also: Six months after legalizing marijuana, two big things have happened in Colorado)
The Community Anti-Drug Coalition of America (CADCA), one of the largest anti-legalization organizations in the US has a curious sponsor: Purdue Pharma, the manufacturer of Oxy-Contin, the highly addictive painkiller that has been linked to thousands of overdose deaths nationwide. A familiar confederation of anti-pot interests have a financial stake in the status quo, including law enforcement agencies, pharmaceutical firms, and nonprofits funded by federal drug-prevention grants.